The Barre-Montpelier Times Argus

Aspire Biopharma Files Provisional Patent Application for Industry-First Sublingual Powder Formulation of Clopidogrel (Generic Plavix(R)) to Address Gastric Bleeding Risks

New sublingual delivery system designed to enhance bioavailability and avoid gastric side effects many patients experience with clopidogrel.

Clopidogrel shown to be superior to aspirin for long-term antiplatelet therapy after coronary stenting

A research team has demonstrated that clopidogrel is more effective than aspirin as a long-term antiplatelet therapy in ...
Reuters

Astra drug beats Plavix in prevention

BARCELONA (Reuters) - AstraZeneca's new pill Brilinta for preventing heart attacks works better than Plavix, the world's second biggest selling drug, without increasing the amount of life-threatening ...
Reuters

Lilly drug beats double dose of Plavix in trial

NEW YORK, Oct 23 (Reuters) - A small study presented on Monday suggests Eli Lilly and Co.'s experimental blood clot preventer prasugrel works faster and could be more effective than the commonly used ...
Newsday

Drug companies to pay Hawaii $700 million to settle Plavix blood thinner lawsuit

HONOLULU — Pharmaceutical companies have agreed to pay Hawaii $700 million to settle its lawsuit over the efficacy and safety of the blood thinner Plavix, the state attorney general's office announced ...